MAPS Seeks FDA Approval For MDMA-Assisted Therapy
A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of MDMA-assisted therapy. The application, which was submitted by MAPS Public Benefit Corporation (MAPS PBC) after more than three decades of clinical research into the potential